The promise and challenges of pharmacogenomics in psychiatry

Pharmacogenomics (PGx) is an expanding field within precision medicine that is poised to play a crucial role in optimising patient outcomes, particularly in the realm of psychiatry. The remission rate for the initial antidepressant prescribed in the Sequenced Treatment Alternatives to Relieve Depre...

Full description

Saved in:
Bibliographic Details
Main Authors: Elaine Ah Gi Lo, Yi Min Wan, Cyrus Su Hui Ho
Format: Article
Language:English
Published: Academy of Medicine Singapore 2024-12-01
Series:Annals, Academy of Medicine, Singapore
Online Access:https://annals.edu.sg/the-promise-and-challenges-of-pharmacogenomics-in-psychiatry/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544082042650624
author Elaine Ah Gi Lo
Yi Min Wan
Cyrus Su Hui Ho
author_facet Elaine Ah Gi Lo
Yi Min Wan
Cyrus Su Hui Ho
author_sort Elaine Ah Gi Lo
collection DOAJ
description Pharmacogenomics (PGx) is an expanding field within precision medicine that is poised to play a crucial role in optimising patient outcomes, particularly in the realm of psychiatry. The remission rate for the initial antidepressant prescribed in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial was only approximately 30%, underscoring the need for more personalised approaches to prescribing.1 For psychiatric patients who may show resistance towards pharmacotherapy, PGx offers promise in reducing adverse effects and enhancing therapeutic efficacy. Personalised pharmacotherapy provides reassurance and potentially mitigates the nocebo effects and somatic symptom exacerbation that are prevalent among these patients.
format Article
id doaj-art-7017be36d5ce41f9953e99f40a8f8b56
institution Kabale University
issn 2972-4066
language English
publishDate 2024-12-01
publisher Academy of Medicine Singapore
record_format Article
series Annals, Academy of Medicine, Singapore
spelling doaj-art-7017be36d5ce41f9953e99f40a8f8b562025-01-13T03:06:11ZengAcademy of Medicine SingaporeAnnals, Academy of Medicine, Singapore2972-40662024-12-01531271071210.47102/annals-acadmedsg.2024367The promise and challenges of pharmacogenomics in psychiatryElaine Ah Gi LoYi Min WanCyrus Su Hui Ho Pharmacogenomics (PGx) is an expanding field within precision medicine that is poised to play a crucial role in optimising patient outcomes, particularly in the realm of psychiatry. The remission rate for the initial antidepressant prescribed in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial was only approximately 30%, underscoring the need for more personalised approaches to prescribing.1 For psychiatric patients who may show resistance towards pharmacotherapy, PGx offers promise in reducing adverse effects and enhancing therapeutic efficacy. Personalised pharmacotherapy provides reassurance and potentially mitigates the nocebo effects and somatic symptom exacerbation that are prevalent among these patients.https://annals.edu.sg/the-promise-and-challenges-of-pharmacogenomics-in-psychiatry/
spellingShingle Elaine Ah Gi Lo
Yi Min Wan
Cyrus Su Hui Ho
The promise and challenges of pharmacogenomics in psychiatry
Annals, Academy of Medicine, Singapore
title The promise and challenges of pharmacogenomics in psychiatry
title_full The promise and challenges of pharmacogenomics in psychiatry
title_fullStr The promise and challenges of pharmacogenomics in psychiatry
title_full_unstemmed The promise and challenges of pharmacogenomics in psychiatry
title_short The promise and challenges of pharmacogenomics in psychiatry
title_sort promise and challenges of pharmacogenomics in psychiatry
url https://annals.edu.sg/the-promise-and-challenges-of-pharmacogenomics-in-psychiatry/
work_keys_str_mv AT elaineahgilo thepromiseandchallengesofpharmacogenomicsinpsychiatry
AT yiminwan thepromiseandchallengesofpharmacogenomicsinpsychiatry
AT cyrussuhuiho thepromiseandchallengesofpharmacogenomicsinpsychiatry
AT elaineahgilo promiseandchallengesofpharmacogenomicsinpsychiatry
AT yiminwan promiseandchallengesofpharmacogenomicsinpsychiatry
AT cyrussuhuiho promiseandchallengesofpharmacogenomicsinpsychiatry